IMAC (BACK) Competitors $0.67 -0.03 (-4.72%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$0.67 +0.01 (+0.75%) As of 02/21/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends BACK vs. ATPC, ACON, NIVF, BTTX, UPHL, ACONW, AONC, DHACW, CORBF, and LFMDPShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Agape ATP (ATPC), Aclarion (ACON), NewGenIvf Group (NIVF), Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), and LifeMD (LFMDP). These companies are all part of the "healthcare" industry. IMAC vs. Agape ATP Aclarion NewGenIvf Group Better Therapeutics UpHealth Aclarion American Oncology Network Digital Health Acquisition Global Cord Blood LifeMD IMAC (NASDAQ:BACK) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, community ranking, media sentiment, institutional ownership and profitability. Does the media prefer BACK or ATPC? In the previous week, IMAC had 5 more articles in the media than Agape ATP. MarketBeat recorded 5 mentions for IMAC and 0 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.00 beat IMAC's score of -0.12 indicating that Agape ATP is being referred to more favorably in the news media. Company Overall Sentiment IMAC Neutral Agape ATP Neutral Does the MarketBeat Community prefer BACK or ATPC? IMAC and Agape ATP both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformIMACOutperform VotesNo VotesUnderperform Votes1100.00% Agape ATPN/AN/A Which has preferable valuation and earnings, BACK or ATPC? Agape ATP has higher revenue and earnings than IMAC. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$72.05K19.15-$9.42MN/AN/AAgape ATP$1.43M2.61-$2.10M-$0.73-1.28 Which has more volatility and risk, BACK or ATPC? IMAC has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, Agape ATP has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500. Do institutionals and insiders believe in BACK or ATPC? 5.8% of IMAC shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 12.3% of IMAC shares are held by insiders. Comparatively, 9.7% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is BACK or ATPC more profitable? IMAC has a net margin of 0.00% compared to Agape ATP's net margin of -194.09%. IMAC's return on equity of 0.00% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets IMACN/A N/A -325.44% Agape ATP -194.09%-74.71%-56.08% SummaryIMAC beats Agape ATP on 6 of the 11 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.36M$1.69B$5.84B$9.14BDividend YieldN/A0.27%4.75%3.85%P/E RatioN/A3.2526.0419.11Price / Sales19.1519.24447.4676.36Price / CashN/A8.3138.0134.83Price / Book-1.011.317.644.62Net Income-$9.42M$36.27M$3.18B$245.85M7 Day Performance4.06%-4.87%-2.00%-2.61%1 Month Performance-50.48%-31.18%-0.44%-2.14%1 Year Performance-54.55%-55.51%16.44%12.98% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$0.67-4.7%N/A-58.1%$1.36M$72,050.000.00180News CoverageGap DownATPCAgape ATPN/A$1.04-18.1%N/A-86.6%$4.15M$1.43M-1.4240ACONAclarion2.2036 of 5 stars$4.67-12.9%$435.50+9,225.5%-99.0%$2.38M$80,000.000.007Gap DownNIVFNewGenIvf Group2.28 of 5 stars$0.12-10.4%N/AN/A$1.36M$5.14M0.00N/ANews CoverageGap UpHigh Trading VolumeBTTXBetter TherapeuticsN/A$0.00+∞N/A-99.8%$5,000.00N/A0.0040Gap UpUPHLUpHealthN/A$0.00flatN/A-99.9%$4,000.00$130M0.001,750ACONWAclarionN/A$0.08+31.7%N/A+306.9%$0.00$49,289.000.007Gap DownAONCAmerican Oncology NetworkN/A$5.30+1.0%N/A-21.5%$0.00$1.34B0.001,520Gap DownDHACWDigital Health AcquisitionN/A$0.05+0.2%N/A-20.5%$0.00N/A0.00N/ACORBFGlobal Cord BloodN/A$0.99-1.0%N/A-45.4%$0.00$196.12M0.001,200LFMDPLifeMDN/A$22.57-0.1%N/A+13.2%$0.00$193.06M0.00230 Related Companies and Tools Related Companies Agape ATP Competitors Aclarion Competitors NewGenIvf Group Competitors Better Therapeutics Competitors UpHealth Competitors Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors Global Cord Blood Competitors LifeMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BACK) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BACK Stock Alerts